Medicare Advantage beneficiaries enroll in only a few plans














Nationwide, 283 insurers have some form of contract to sponsor a Medicare Advantage or other prepaid group plan. MA plans are set up geographically. That means that 99 percent of beneficiaries have a choice of plans to choose from, according to report by the Kaiser Family Foundation called Strategies for Simplifying the Medicare Advantage Market.

Yet while many insurers participate in the individual MA market, national enrollment tends to be concentrated with a small number of insurers. One in three individual enrollees is in a plan sponsored by either UnitedHealthcare (18 percent) or Humana (15 percent). These and nine other insurers account for more than half of all enrollment. Another 16 percent of enrollees are involved with insurers that are independently owned by a Blue Cross & Blue Shield affiliate.

MA enrollment by insurer or affiliate, 2009

Note: Excludes group and special needs plans. Only enrollees in authorized MA plans are included.

Source: The Henry J. Kaiser Family Foundation, Strategies for Simplifying the Medicare Advantage Market, July 2009

Career Opportunities

HAP, a subsidiary of Henry Ford Health System, is a nonprofit health plan providing coverage to individuals, companies and organizations. This executive develops strategies to meet membership and revenue targets through products, pricing, market segmentation and advertising.  Aligns business among Business Development, Commercial Sales, Medicare and Public Sector Programs and Product Development. Seeks to enhance and be responsible for business development and expansion through the development of an effective product portfolio, strong interpersonal relationships and service excellence.

Apply via email to jfedder1@hfhs.org or online at http://p.rfer.us/HENRYFORDlXqAJA

Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.